Jonathan Kimmelman
Biography:
Jonathan Kimmelman's research group, STREAM, studies the ethical, policy, and scientific dimensions of drug development and clinical trials. Kimmelman also directs º«¹úÂãÎè's Biomedical Ethics Unit, and has served in numerous policy committees, including four tours of duty on U.S. National Academy of Medicine committees.
Areas of expertise:
Meta-research, clinical trials, research ethics, drug development, pharmaceutical policy, medical decision-making, risk
Group:
Associate Members
Research areas:
Clinical Epidemiology and Informatics
Health Services and Health Policy
Areas of interest:
Keywords:Â cancer, neurology, cell therapy, gene therapy, phase 1 trials